Molecular landscapes of human hematopoietic stem cells in health and leukemia

Annals of the New York Academy of Sciences

Volumn 1370, Issue 1, 2016, Pages 5-14

  Vedi, Aditi ^a,b   Santoro, Antonella ^a   Dunant, Cyrille F ^c   Dick, John E ^d,e   Laurenti, Elisa ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c EPFL   (Switzerland)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

acute myeloid leukemia; epigenetics; hematopoietic stem cells; transcriptomics

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER PROGNOSIS; CELL DIFFERENTIATION; DNA MODIFICATION; EPIGENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PROGENY; SINGLE CELL ANALYSIS; TISSUE ENGINEERING; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

EID: 84976619586     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12981     Document Type: Article

References (78)

1. Wilson, A, E. Laurenti, G. Oser, et al. 2008. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135: 1118–1129.
2. Foudi, A, K. Hochedlinger, D. Van Buren, et al. 2009. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat. Biotechnol. 27: 84–90.
3. Takizawa, H, R.R. Regoes, C.S. Boddupalli, et al. 2011. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J. Exp. Med. 208: 273–284.
4. Nakamura-Ishizu, A, H. Takizawa & T. Suda . 2014. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 141: 4656–4666.
5. Ito, K. & T. Suda . 2014. Metabolic requirements for the maintenance of self-renewing stem cells. Nat. Rev. Mol. Cell Biol. 15: 243–256.
6. Boulais, P.E. & P.S. Frenette . 2015. Making sense of hematopoietic stem cell niches. Blood 125: 2621–2629.
7. Doulatov, S, F. Notta, E. Laurenti, et al. 2012. Hematopoiesis: a human perspective. Cell Stem Cell 10: 120–136.
8. Majeti, R, C.Y. Park & I.L. Weissman . 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1: 635–645.
9. Doulatov, S, F. Notta, K. Eppert, et al. 2010. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 11: 585–593.
10. Goardon, N, E. Marchi, A. Atzberger, et al. 2011. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19: 138–152.
11. Kohn, L.A, Q.-L. Hao, R. Sasidharan, et al. 2012. Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin. Nat. Immunol. 13: 963–971.
12. Notta, F, S. Doulatov, E. Laurenti, et al. 2011. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218–221.
13. Novershtern, N, A. Subramanian, L.N. Lawton, et al. 2011. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144: 296–309.
14. Gentles, A.J, S.K. Plevritis, R. Majeti & A.A. Alizadeh . Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304: 2706–2715.
15. Laurenti, E, S. Doulatov, S. Zandi, et al. 2013. The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat. Immunol. 14: 756–763.
16. Chen, L, M. Kostadima, J.H.A. Martens, et al. 2014. Transcriptional diversity during lineage commitment of human blood progenitors. Science 345: 1251033.
17. Chambers, S.M, N.C. Boles, K.-Y.K. Lin, et al. 2007. Hematopoietic fingerprints: an expression database of stem cells and their progeny. Cell Stem Cell 1: 578–591.
18. Gazit, R, B.S. Garrison, T.N. Rao, et al. 2013. Transcriptome analysis identifies regulators of hematopoietic stem and progenitor cells. Stem Cell Rep. 1: 266–280.
19. Milyavsky, M, O.I. Gan, M. Trottier, et al. 2010. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7: 186–197.
20. Mohrin, M, E. Bourke, D. Alexander, et al. 2010. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7: 174–185.
21. van Galen, P, A. Kreso, N. Mbong, et al. 2014. The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress. Nature 510: 268–272.
22. Miharada, K, V. Sigurdsson & S. Karlsson . 2014. Dppa5 improves hematopoietic stem cell activity by reducing endoplasmic reticulum stress. Cell Rep. 7: 1381–1392.
23. Zandi, S, D. Bryder & M. Sigvardsson . 2010. Load and lock: the molecular mechanisms of B-lymphocyte commitment. Immunol. Rev. 238: 47–62.
24. van Galen, P, A. Kreso, E. Wienholds, et al. 2014. Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion. Cell Stem Cell 14: 94–106.
25. Beer, P.A, D.J.H.F. Knapp, N. Kannan, et al. A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells. Stem Cell Rep. 3: 841–857.
26. Cabezas-Wallscheid, N, D. Klimmeck, J. Hansson, et al. 2014. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell 15: 507–522.
27. Laurenti, E, C. Frelin, S. Xie, et al. 2015. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell 16: 302–313.
28. Wilson, N.K, D.G. Kent, F. Buettner, et al. 2015. Combined single-cell functional and gene expression analysis resolves heterogeneity within stem cell populations. Cell Stem Cell 16: 712–724.
29. Kowalczyk, M.S, I. Tirosh, D. Heckl, et al. 2015. Single cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. doi:10.1101/gr.192237.115
30. Tsang, J.C, Y. Yu, S. Burke, et al. 2015. Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells. Genome Biol. 16: 178.
31. Cosgun, K.N, S. Rahmig, N. Mende, et al. 2014. Kit regulates HSC engraftment across the human-mouse species barrier. Cell Stem Cell 15: 227–238.
32. Luo, M, M. Jeong, D. Sun, et al. 2015. Long non-coding RNAs control hematopoietic stem cell function. Cell Stem Cell 16: 426–438.
33. Ramos, A.D, R.E. Andersen, S.J. Liu, et al. 2015. The long noncoding RNA Pnky regulates neuronal differentiation of embryonic and postnatal neural stem cells. Cell Stem Cell 16: 439–447.
34. Kim, D.H, G.K. Marinov, S. Pepke, et al. 2015. Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming. Cell Stem Cell 16: 88–101.
35. Gabut, M, P. Samavarchi-Tehrani, X. Wang, et al. 2011. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147: 132–146.
36. Sykes, S.M. & D.T. Scadden . 2013. Modeling human hematopoietic stem cell biology in the mouse. Semin. Hematol. 50: 92–100.
37. Pang, W.W, J.V. Pluvinage, E.A. Price, et al. 2013. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc. Natl. Acad. Sci. U.S.A. 110: 3011–3016.
38. Geiger, H, G. de Haan & M.C. Florian . 2013. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 13: 376–389.
39. Flach, J, S.T. Bakker, M. Mohrin, et al. 2014. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512: 198–202.
40. Beerman, I, C. Bock, B.S. Garrison, et al. 2013. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 12: 413–425.
41. Rossi, D.J, D. Bryder, J.M. Zahn, et al. 2005. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl. Acad. Sci. U. S. A. 102: 9194–9199.
42. Bock, C, I. Beerman, W.-H. Lien, et al. 2012. DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol. Cell 47: 633–647.
43. Bocker, M.T, I. Hellwig, A. Breiling, et al. 2011. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood 117: e182–e189.
44. Sun, D, M. Luo, M. Jeong, et al. 2014. Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell 14: 673–688.
45. Cui, K, C. Zang, T.-Y. Roh, et al. 2009. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4: 80–93.
46. Weishaupt, H, M. Sigvardsson & J.L. Attema . 2010. Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood 115: 247–256.
47. Lara-Astiaso, D, A. Weiner, E. Lorenzo-Vivas, et al. 2014. Chromatin state dynamics during blood formation. Science 345: 943–949.
48. Wittkopp, P.J. & G. Kalay . 2012. Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence. Nat. Rev. Genet. 13: 59–69.
49. Jaiswal, S, P. Fontanillas, J. Flannick, et al. 2014. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371: 2488–2498.
50. Busque, L, J.P. Patel, M.E. Figueroa, et al. 2012. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat. Genet. 44: 1179–1181.
51. Genovese, G, A.K. Kähler, R.E. Handsaker, et al. 2014. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371: 2477–2487.
52. Xie, M, C. Lu, J. Wang, et al. 2014. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20: 1472–1478.
53. McKerrell, T, N. Park, T. Moreno, et al. 2015. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 10: 1239–1245.
54. Dick, J.E. 2008. Stem cell concepts renew cancer research. Blood 112: 4793–4807.
55. Visvader, J.E. 2011. Cells of origin in cancer. Nature 469: 314–322.
56. Kreso, A. & J.E. Dick . 2014. Evolution of the cancer stem cell model. Cell Stem Cell 14: 275–291.
57. Bonnet, D. & J.E. Dick . 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3: 730–737.
58. Jordan, C.T, M.L. Guzman & M. Noble . 2006. Cancer stem cells. N. Engl. J. Med. 355: 1253–1261.
59. Lapidot, T, C. Sirard, J. Vormoor, et al. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645–648.
60. Eppert, K, K. Takenaka, E.R. Lechman, et al. 2011. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17: 1086–1093.
61. + cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. Blood 116: 3907–3922.
62. Taussig, D.C, F. Miraki-Moud, F. Anjos-Afonso, et al. 2008. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112: 568–575.
63. Sarry, J.-E, K. Murphy, R. Perry, et al. 2011. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL-2Rγc-deficient mice. J. Clin. Invest. 121: 384–395.
64. Majeti, R, M.W. Becker, Q. Tian, et al. 2009. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl. Acad. Sci. U.S.A. 106: 3396–3401.
65. Saito, Y, H. Kitamura, A. Hijikata, et al. 2010. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci. Transl. Med. 2: 17ra9.
66. Barreyro, L, B. Will, B. Bartholdy, et al. 2012. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood 120: 1290–1298.
67. Somervaille, T.C.P. & M.L. Cleary . 2006. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10: 257–268.
68. Wong, S.H.K, D.L. Goode, M. Iwasaki, et al. 2015. The H3K4-methyl epigenome regulates leukemia stem cell oncogenic potential. Cancer Cell 28: 198–209.
69. Levine, J.H, E.F. Simonds, S.C. Bendall, et al. 2015. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162: 184–197.
70. Alexandrov, L.B, S. Nik-Zainal, D.C. Wedge, et al. 2013. Signatures of mutational processes in human cancer. Nature 500: 415–421.
71. Wilson, N.K, S.D. Foster, X. Wang, et al. 2010. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7: 532–544.
72. Diffner, E, D. Beck, E. Gudgin, et al. 2013. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood 121: 2289–2300.
73. Müller-Tidow, C, H.-U. Klein, A. Hascher, et al. 2010. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood 116: 3564–3571.
74. Moti, N, T. Malcolm, R. Hamoudi, et al. 2014. Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin. Oncogene 34: 1843–1852.
75. Zhang, J, L. Ding, L. Holmfeldt, et al. 2012. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481: 157–163.
76. Rongvaux, A, H. Takizawa, T. Strowig, et al. 2013. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu. Rev. Immunol. 31: 635–674.
77. Goyama, S, M. Wunderlich & J.C. Mulloy . 2015. Xenograft models for normal and malignant stem cells. Blood 125: 2630–2640.
78. Vo, L.T. & G.Q. Daley . 2015. De novo generation of HSCs from somatic and pluripotent stem cell sources. Blood 125: 2641–2648.